DM medications Flashcards
What are the examples and the the MOA of biguanides?
Metformin 250-850mg OM-TDS
Activates ANP kinase, β hepatic gluconeogenesis
βinsulin sensitivity for muscle glucose uptake
What are the advantages of metformin?
Cheap
Weight-neutral / loss
Min Hypogly Events Does not affect insulin production = no islet cell fatigue
What are the disadvantages of metformin?
GI S/E: diarrhoea, abdominal bloating, and nausea.
Metallic taste
B12 deficiency
Risk of lactic acidosis (very rare): Potentiates HAGMA if pt is alr acidotic /has renal impairment
- eGFR <30: Avoid
- eGFR 30-60: Max 1g/day
- eGFR >60: Safe
C/I in pt w/ renal, hepatic or cardiac impairment π‘ͺ worsens lactic acidosis, Stop before giving contrast for imaging
What are the examples of sulfonylureas?
1st gen β tolbutamide, chlorpropamide
2nd gen β glibenclamide, gliclazide, glipizide
3rd gen β glimepiride
What are the MOAs of sulfonylureas?
Closes potassium ATP channels and opening calcium channels on beta-islet cell surface receptors, increasing insulin secretion
What are the advantages of sulfonylureas?
Thought to reduce microvascular risk
Elderly Friendly β tolbutamide (short TΒ½)
CKD friendly β only gliclazide and glipizide, but gliclazide may require renal dose adjustment
What are the disadvantages of sulfonylureas?
Can cause significant hypoglycaemia and weight gain, especially long-acting sulfonylureas like glibenclamide
Not useful in patients with pancreatic insufficiency (late stage) or T1DM
What are the examples of GLP-1 mimetics (glucagon like peptide)
Activates GLP-1 receptors to enhance incretin effect:
1) βglucose-stimulated Insulin Release
2) Suppress Glucagon
What are the examples of GLP-1 mimetics?
exenatide, liraglutide
What are advantages of GLP-1 mimetics?
Induces weight loss (b/c β Insulin, Inhibit glucagon, β Appetite, Delay gastric emptying)
What are disadvantages of GLP-1 mimetics?
Must be given s/c
GI disturbances of nausea, vomiting, abdominal distension, diarrhoea
Headache, dizziness, diaphoresis
C/I in pregnancy, breastfeeding, FHx of MTC (medullary thyroid Dz) or MEN2
Not useful in patients with pancreatic insufficiency (late stage)
Small risk of pancreatitis β use w caution in pt with hx of pancreatitis
Not recommended in patients with moderate-severe renal impairment
What is the MOA of DPP4- inhibitors?
Inhibits DPP-4, an enzyme which breaks down GLP-1 and GIP (GI poplypeptide) incretins
What are examples of DPP4 inhibitors?
sitagliptin, linagliptin, vildagliptin
What are the advantages of DPP-4 inhibitors?
Weight neutral
GIT (diarrhea, constipation, nausea), nasopharyngitis
Good S/E profile, a/w minimal Hypogly events
CKD friendly π β but sitagliptin require renal dose adjustment
What are the disadvantages of DPP-4 inhibitors?
Causes urticaria in some patients, and rarely angioedema
Not useful in patients with pancreatic insufficiency (late stage)
Small risk of pancreatitis β use w caution in pt with hx of pancreatitis
What are examples of Alpha-glucosidase inhibitors?
arbacabose
What is the MOA of Alpha-glucosidase inhibitors?
Inhibits Ξ±-glucosidase which breaks carbs into monosaccharide components, retarding glucose uptake in the intestine
What is the advantages of Alpha-glucosidase inhibitors?
Helps to reduce post-prandial glycaemic index
What is the disadvantages of Alpha-glucosidase inhibitors?
- Needs to be taken thrice daily
- SE a/w increased delivery of undigested starch to colon for fermentation: bloating, flatulence, and diarrhoea
- Provides minimal A1c reduction. Being phased out
What are examples of SGLT-2 inhibitors?
dapagliflozin, canagliflozin, empaglifozin
What is the MOA of SGLT2 inhibitors?
Inhibits SGLT-2 in the proximal nephron, hence prevents glucose reabsorption and increases glycosuria
What is the advantages of SGLT2 inhibitors?
Induces LOW b/c does not drive glucose into tissue
Good S/E profile, a/w Min Hypogly events
Cardioprotective (against HF dev)
What is the disadvantages of SGLT2 inhibitors?
Increased risk of UTI
Increased risk of genital mycotic infections
Polyuria
Dose-related risk of volume depletion, dehydration
LDL increase
Risk of euglycemic DKA
C/I if CrCl <45 π‘ͺ inc risk of pre-renal impairment because of dehydration
Will not recommend in BPH patients / bedbound / diapers π‘ͺ impaired urine clearance and worse genital hygiene
What do you need to counsel patients on when they are on SGLT2 inhibitors?
Empty bladder regularly π‘ͺ the longer they hold the higher the risk of infection (because urine very sweet), and important for proper
Hygiene π‘ͺ clean perineal region after urination
Need to stop 2 days before any elective procedure
Need to stop on day of acute hospital admission
When severely sick w/ vomiting high fever π‘ͺ need to stop SGLT2 inhibitor (no need to stop for mild illnesses / mild URTI)
Ramadan π‘ͺ body in stressed state hence must stop SGLT2 inhibitors as well